A Study of an Ad26.RSV.preF-based Regimen in the Prevention of Reverse Transcriptase Polymerase Chain Reaction (RT-PCR)-Confirmed Respiratory Syncytial Virus (RSV)-Mediated Lower Respiratory Tract Disease in Adults Aged 65 Years and Older

Clinical trial NCT03982199 · TERMINATED

Trial details

NCT number: NCT03982199
Sponsor: Janssen Vaccines & Prevention B.V.
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Respiratory Syncytial Viruses Respiratory Tract Diseases

Start date: 2019-08-01
Primary completion: 2022-06-06
Enrollment: 5815

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.